S
4.17
-0.04 (-0.95%)
| Penutupan Terdahulu | 4.21 |
| Buka | 4.11 |
| Jumlah Dagangan | 44,750 |
| Purata Dagangan (3B) | 183,998 |
| Modal Pasaran | 215,597,760 |
| Harga / Jualan (P/S) | 2.73 |
| Harga / Buku (P/B) | 2.80 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Jul 2025 - 4 Aug 2025 |
| Margin Keuntungan | -63.24% |
| Margin Operasi (TTM) | -79.16% |
| EPS Cair (TTM) | -0.980 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -9.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.12% |
| Nisbah Semasa (MRQ) | 10.47 |
| Aliran Tunai Operasi (OCF TTM) | -24.17 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.84 M |
| Pulangan Atas Aset (ROA TTM) | -21.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -52.88% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Sight Sciences, Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.3
| Konsensus Penganalisis | -5.0 |
| Aktiviti Orang Dalam | 3.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.30 |
|
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 20.93% |
| % Dimiliki oleh Institusi | 50.88% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Kck Ltd. | 31 Dec 2024 | 4,374,975 |
| Prosight Management, Lp | 31 Mar 2025 | 969,287 |
| B Group, Inc. | 31 Mar 2025 | 833,600 |
| Apollo Management Holdings, L.P. | 31 Mar 2025 | 671,520 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 3.60 (Citigroup, -13.67%) | Pegang |
| Median | 3.30 (-20.86%) | |
| Rendah | 3.00 (Lake Street, -28.06%) | Pegang |
| Purata | 3.30 (-20.86%) | |
| Jumlah | 2 Pegang | |
| Harga Purata @ Panggilan | 3.18 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 22 May 2025 | 3.60 (-13.67%) | Pegang | 3.28 |
| Lake Street | 09 May 2025 | 3.00 (-28.06%) | Pegang | 3.08 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ENCRANTZ STAFFAN | 4.13 | - | 177,506 | 732,303 |
| FOUNTAIN TAMARA | 4.20 | - | 30,952 | 129,998 |
| LARSEN-BECKER BRENDA JANE | 4.20 | - | 30,952 | 129,998 |
| MAZZACCO CATHERINE | 4.20 | - | 30,952 | 129,998 |
| ROGERS ERICA J. | 4.20 | - | 30,952 | 129,998 |
| ZURBAY DONALD | 4.20 | - | 30,952 | 129,998 |
| Jumlah Keseluruhan Kuantiti Bersih | 332,266 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 1,382,295 | |||
| Purata Pembelian Keseluruhan ($) | 4.16 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| ENCRANTZ STAFFAN | Pengarah | 06 Jun 2025 | Beli (+) | 27,900 | 4.20 | 117,180 |
| ENCRANTZ STAFFAN | Pengarah | 05 Jun 2025 | Beli (+) | 40,951 | 4.20 | 171,994 |
| ENCRANTZ STAFFAN | Pengarah | 05 Jun 2025 | Diperolehi (+) | 30,952 | 4.20 | 129,998 |
| ZURBAY DONALD | Pengarah | 05 Jun 2025 | Diperolehi (+) | 30,952 | 4.20 | 129,998 |
| FOUNTAIN TAMARA | Pengarah | 05 Jun 2025 | Diperolehi (+) | 30,952 | 4.20 | 129,998 |
| ROGERS ERICA J. | Pengarah | 05 Jun 2025 | Diperolehi (+) | 30,952 | 4.20 | 129,998 |
| LARSEN-BECKER BRENDA JANE | Pengarah | 05 Jun 2025 | Diperolehi (+) | 30,952 | 4.20 | 129,998 |
| MAZZACCO CATHERINE | Pengarah | 05 Jun 2025 | Diperolehi (+) | 30,952 | 4.20 | 129,998 |
| ENCRANTZ STAFFAN | Pengarah | 04 Jun 2025 | Beli (+) | 21,674 | 4.24 | 91,898 |
| ENCRANTZ STAFFAN | Pengarah | 03 Jun 2025 | Beli (+) | 25,230 | 4.02 | 101,425 |
| ENCRANTZ STAFFAN | Pengarah | 02 Jun 2025 | Beli (+) | 30,799 | 3.89 | 119,808 |
| Papar semua | ||||||
| Tarikh | Jenis | Butiran |
|---|---|---|
| 14 May 2025 | Pengumuman | Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th |
| 08 May 2025 | Pengumuman | Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance |
| 24 Apr 2025 | Pengumuman | Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025 |
| 23 Apr 2025 | Pengumuman | Sight Sciences Announces the Release of its Sustainability Report |
| 22 Apr 2025 | Pengumuman | Sight Sciences Appoints Gary Burbach to its Board of Directors |
| 21 Apr 2025 | Pengumuman | Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio |
| 25 Mar 2025 | Pengumuman | Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |